Reports

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Allergy Diagnostics and Therapeutics Market: By Product: Instruments, Consumables, Services; By Allergen Type: Food, Inhaled, Drug; By End Use; By Diagnostic Tests; By Drug Class; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics; Competitive Landscape; Industry Events and Developments

Global Allergy Diagnostics & Therapeutics Market Outlook

The global allergy diagnostics & therapeutics market was estimated at USD 34.1 billion in 2020 and is projected to increase further over the forecast period of 2022-2027 at a CAGR of 6.5%.

 

Rising incidences of allergic diseases, coupled with high demand for blood tests for in vitro diagnosis, are anticipated to drive the industry growth of the allergy diagnostics & therapeutics in the coming years.

 

Global Allergy Diagnostics and Therapeutics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Properties and Applications

The allergy diagnostics & therapeutics market can be divided on the basis of segments like product, allergen type, end-use, diagnostic tests, and drug class. The industry can be broadly categorised on the basis of product into:

 

Global Allergy Diagnostics and Therapeutics Market By Product

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

  • Instruments
  • Consumables
  • Services

The industry can be categorised on the basis of allergen type into:

  • Food
  • Inhaled
  • Drug
  • Others

The industry can be divided based on end-uses into:

  • Diagnostics labs
  • Hospitals
  • Academic Research Institutes

The industry can be divided on the basis of diagnostic tests as:

  • In-Vivo
  • Skin Prick Test
  • Intradermal
  • Patch Test
  • In-Vitro

The industry can be segmented based on drug class as:

  • Antihistamines
  • Decongestants
  • Corticosteroids
  • Mast Cell Stabilizers
  • Leukotriene Inhibitors
  • Nasal Anticholinergics
  • Immunomodulators
  • Autoinjectable Epinephrine
  • Immunotherapy

The EMR report looks into the regional markets of allergy diagnostics & therapeutics like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific regions.

 

Global Allergy Diagnostics and Therapeutics Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

The growth of the allergy diagnostics & therapeutics industry is expected to be driven by a number of factors, such as the high incidence and high economic burden of allergic diseases, increased healthcare spending, and increased access to medical insurance in the United States. Within allergy testing, factors such as widespread availability and high consumption of assay kits are expected to drive the development of this segment in the following years. The category of inhaled allergens is projected to represent the largest share of the market for allergy diagnostics in the forecast period. Increasing environmental pollution is one of the main factors driving the market growth. Growing investments, rising research activities, and increasing acceptance from the United States for allergy treatment via medical insurance are the key factors accelerating the market growth.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global allergy diagnostics & therapeutics market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • BioMérieux 9BIM (EPA)
  • Danaher Corporation (NYSE: DHR)
  • Thermo Fisher Scientific
  • Stallergenes Greer Plc
  • Hitachi Chemical Diagnostics, Inc.
  • Siemens Healthineers AG 
  • Omega Diagnostics Group  
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter's Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Allergen Type, End Use, Diagnostic Tests, Drug Class, Region
Breakup by Product Instruments, Consumables, Services
Breakup by Allergen Type Food, Inhaled, Drug, Others
Breakup by End Use Diagnostics labs, Hospitals, Academic Research Institutes
Breakup by Diagnostic Tests In-Vivo, Skin Prick Test, Intradermal, Patch Test, In-Vitro
Breakup by Drug Class Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anticholinergics, Immunomodulators, Autoinjectable Epinephrine, Immunotherapy
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered BioMérieux 9BIM (EPA)), Danaher Corporation (DHR (NYSE)),
Thermo Fisher Scientific, Stallergenes Greer Plc, Hitachi Chemical Diagnostics, Inc.,
Siemens Healthineers AG (SHL (ETR)), Omega Diagnostics Group (ODX (LON)), Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
    1.1    Objectives of the Study
        1.1.1    Research Objective
        1.1.2    Key Findings of the Report
2    Research Methodology
    2.1    Data Extraction
    2.2    Data Corroboration
    2.3    Market Structure
    2.4    Assumptions
    2.5    Market Models
3    Introduction
    3.1    Market Outlook
    3.2    Market Scope and Segmentation
    3.3    Additional Insights
4    Executive Summary
    4.1    Key Market Developments
    4.2    Market Analysis
    4.3    Key Players
    4.4    Cost Structure
    4.5    Market Revenue and Growth
5    Market Dynamics
    5.1    Market Driver Analysis
    5.2    Market Restraint Analysis
    5.3    Industry Challenges
    5.4    Industry Opportunities
6    Global Allergy Diagnostics & Therapeutics Market Analysis
    6.1    Global Allergy Diagnostics & Therapeutics Historical Market (2017-2021) & Forecast (2022-2027)
    6.2    Global Allergy Diagnostics & Therapeutics Market Breakup by Product
        6.2.1    Instruments
        6.2.2    Consumables
        6.2.3    Services
    6.3     Global Allergy Diagnostics & Therapeutics Market Breakup by Product: Historical Market (2017-2021) & Forecast (2022-2027)
        6.3.1    Instruments
        6.3.2    Consumables
        6.3.3    Services
    6.4    Global Allergy Diagnostics & Therapeutics Market by Allergen Type
        6.4.1    Food
        6.4.2    Inhaled
        6.4.3    Drug
        6.4.4    Others
    6.5    Global Allergy Diagnostics & Therapeutics Market by Allergen Type: Historical Market (2017-2021) & Forecast (2022-2027)
        6.5.1    Food
        6.5.2    Inhaled
        6.5.3    Drug
        6.5.4    Others
    6.6    Global Allergy Diagnostics & Therapeutics Market by End Use 
        6.6.1    Diagnostics labs
        6.6.2    Hospitals
        6.6.3    Academic Research Institutes 
    6.7    Global Allergy Diagnostics & Therapeutics Market by End Use: Historical Market (2017-2021) & Forecast (2022-2027)
        6.7.1    Diagnostics labs
        6.7.2    Hospitals
        6.7.3    Academic Research Institutes 
    6.8    Global Allergy Diagnostics & Therapeutics Market by Diagnostic Tests
        6.8.1    In-Vivo
        6.8.2    Skin Prick Test
        6.8.3    Intradermal
        6.8.4    Patch Test
        6.8.5    In-Vitro
    6.9    Global Allergy Diagnostics & Therapeutics Market by Diagnostic Tests: Historical Market (2017-2021) & Forecast (2022-2027)
        6.9.1    In-Vivo
        6.9.2    Skin Prick Test
        6.9.3    Intradermal
        6.9.4    Patch Test
        6.9.5    In-Vitro
    6.10    Global Allergy Diagnostics & Therapeutics Market by Drug Class
        6.10.1    Antihistamines
        6.10.2    Decongestants
        6.10.3    Corticosteroids
        6.10.4    Mast Cell Stabilizers
        6.10.5    Leukotriene Inhibitors
        6.10.6    Nasal Anticholinergics
        6.10.7    Immunomodulators
        6.10.8    Autoinjectable Epinephrine
        6.10.9    Immunotherapy
    6.11    Global Allergy Diagnostics & Therapeutics Market by Drug Class: Historical Market (2017-2021) & Forecast (2022-2027)
        6.11.1    Antihistamines
        6.11.2    Decongestants
        6.11.3    Corticosteroids
        6.11.4    Mast Cell Stabilizers
        6.11.5    Leukotriene Inhibitors
        6.11.6    Nasal Anticholinergics
        6.11.7    Immunomodulators
        6.11.8    Autoinjectable Epinephrine
        6.11.9    Immunotherapy
    6.12    Global Allergy Diagnostics & Therapeutics Market Breakup by Region
         6.12.1    North America
            6.12.1.1    United States of America
            6.12.1.2    Canada
        6.12.2    Europe
            6.12.2.1    Germany
            6.12.2.2    United Kingdom
            6.12.2.3    France
            6.12.2.4    Italy
            6.12.2.5    Others
        6.12.3    Asia Pacific
            6.12.3.1    China
            6.12.3.2    Japan
            6.12.3.3    India
            6.12.3.4    ASEAN
            6.12.3.5    Others
        6.12.4    Latin America
            6.12.4.1    Brazil
            6.12.4.2    Argentina
            6.12.4.3    Mexico
            6.12.4.4    Others
        6.12.5    Middle East & Africa
            6.12.5.1    Saudi Arabia
            6.12.5.2    United Arab Emirates
            6.12.5.3    Nigeria
            6.12.5.4    South Africa
            6.12.5.5    Others
    6.13     Global Allergy Diagnostics & Therapeutics Breakup by Region: Historical Market (2017-2021) & Forecast (2022-2027)
         6.13.1    North America
            6.13.1.1    United States of America
            6.13.1.2    Canada
        6.13.2    Europe
            6.13.2.1    Germany
            6.13.2.2    United Kingdom
            6.13.2.3    France
            6.13.2.4    Italy
            6.13.2.5    Others
        6.13.3    Asia Pacific
            6.13.3.1    China
            6.13.3.2    Japan
            6.13.3.3    India
            6.13.3.4    ASEAN
            6.13.3.5    Others
        6.13.4    Latin America
            6.13.4.1    Brazil
            6.13.4.2    Argentina
            6.13.4.3    Mexico
            6.13.4.4    Others
        6.13.5    Middle East & Africa
            6.13.5.1    Saudi Arabia
            6.13.5.2    United Arab Emirates
            6.13.5.3    Nigeria
            6.13.5.4    South Africa
            6.13.5.5    Others
7    SWOT Analysis
    7.1    Overview
    7.2    Strengths
    7.3    Weaknesses
    7.4    Opportunities
    7.5    Threats
8    Porter’s Five Forces Analysis
    8.1    Overview
    8.2    Buyer’s Power
    8.3    Supplier’s Power
    8.4    New Entrants
    8.5    Degree of Rivalry
    8.6    Substitutes
9    Competitive Landscape & Supplier Analysis
    9.1    BioMérieux 9BIM (EPA))
        9.1.1    Company Overview
        9.1.2    Financial Analysis
    9.2    Danaher Corporation (DHR (NYSE))
        9.2.1    Company Overview
        9.2.2    Financial Analysis
    9.3    Thermo Fisher Scientific
        9.3.1    Company Overview
        9.3.2    Financial Analysis
    9.4    Stallergenes Greer Plc
        9.4.1    Company Overview
        9.4.2    Financial Analysis
    9.5    Hitachi Chemical Diagnostics, Inc.
        9.5.1    Company Overview
        9.5.2    Financial Analysis
    9.6    Siemens Healthineers AG (SHL (ETR))
        9.6.1    Company Overview
        9.6.2    Financial Analysis
    9.7    Omega Diagnostics Group (ODX (LON))
        9.7.1    Company Overview
        9.7.2    Financial Analysis
    9.8    Others
10    Industry Events and Developments

Key Questions Answered in the Report

The global allergy diagnostics and therapeutics market attained a value of nearly USD 34.1 billion in 2020.

The market is projected to grow at a CAGR of 6.5% between 2021 and 2026.

The major drivers of the market include rising incidences of allergic diseases, coupled with high demand for blood tests for in vitro diagnosis, growing investments, and the rising research activities.

The increasing acceptance from the United States for allergy treatment via medical insurance are the key industry trends propelling the growth of the market.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The product type in the market includes instruments, consumables, and services.

Allergens can be divided into food, inhaled, and drug, among others. Inhaled allergen is the dominant type of allergy diagnostics and therapeutics in the industry.

End uses can be divided into diagnostics labs, hospitals, and academic research institutes.

In-vivo, skin prick test, intradermal, patch test, and in-vitro are the major diagnostic tests in this industry.

The major players in the industry are BioMérieux 9BIM, Danaher Corporation, Thermo Fisher Scientific, Stallergenes Greer Plc, Hitachi Chemical Diagnostics, Inc., Siemens Healthineers AG, and Omega Diagnostics Group, among others.

Analyst Review

The global allergy diagnostics and therapeutics market attained a value of USD 34.1 billion in 2020, driven by the rising incidences of allergic diseases, coupled with high demand for blood tests for in vitro diagnosis. Aided by growing investments, rising research activities, and increasing acceptance from the United States for allergy treatment via medical insurance, the market is expected to witness to further grow at a CAGR of 6.5% in the forecast period of 2022-2027.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. The product type in the market includes instruments, consumables, and services. Based on its allergen type, the allergy diagnostics and therapeutics industry can be segmented into food, inhaled, drug, among others, with inhaled allergen accounting for the largest market share. In-vivo, skin prick test, intradermal, patch test, in-vitro are the major diagnostic tests in this industry. End uses can be divided into diagnostics labs, hospitals, and academic research institutes. The major regional markets for allergy diagnostics and therapeutics are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include BioMérieux 9BIM, Danaher Corporation, Thermo Fisher Scientific, Stallergenes Greer Plc, Hitachi Chemical Diagnostics, Inc., Siemens Healthineers AG and Omega Diagnostics Group, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER